The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Codeine Tablet Market Research Report 2025
Synopsis
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Oral Codeine Tablet market was valued at US$ 681.5 million in 2023 and is anticipated to reach US$ 965 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
This report aims to provide a comprehensive presentation of the global market for Oral Codeine Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Codeine Tablet.
Report Scope
The Oral Codeine Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Codeine Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Codeine Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Codeine Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Codeine Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Oral Codeine Tablet market was valued at US$ 681.5 million in 2023 and is anticipated to reach US$ 965 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
This report aims to provide a comprehensive presentation of the global market for Oral Codeine Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Codeine Tablet.
Report Scope
The Oral Codeine Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Codeine Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Codeine Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Codeine Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Codeine Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Codeine Tablet Market Overview
1.1 Product Overview and Scope of Oral Codeine Tablet
1.2 Oral Codeine Tablet Segment by Type
1.2.1 Global Oral Codeine Tablet Market Value Comparison by Type (2024-2030)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Oral Codeine Tablet Segment by Application
1.3.1 Global Oral Codeine Tablet Market Value by Application: (2024-2030)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Oral Codeine Tablet Market Size Estimates and Forecasts
1.4.1 Global Oral Codeine Tablet Revenue 2019-2030
1.4.2 Global Oral Codeine Tablet Sales 2019-2030
1.4.3 Global Oral Codeine Tablet Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Codeine Tablet Market Competition by Manufacturers
2.1 Global Oral Codeine Tablet Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Codeine Tablet Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Codeine Tablet Average Price by Manufacturers (2019-2024)
2.4 Global Oral Codeine Tablet Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Codeine Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Codeine Tablet, Product Type & Application
2.7 Oral Codeine Tablet Market Competitive Situation and Trends
2.7.1 Oral Codeine Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Codeine Tablet Players Market Share by Revenue
2.7.3 Global Oral Codeine Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Codeine Tablet Retrospective Market Scenario by Region
3.1 Global Oral Codeine Tablet Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Codeine Tablet Global Oral Codeine Tablet Sales by Region: 2019-2030
3.2.1 Global Oral Codeine Tablet Sales by Region: 2019-2024
3.2.2 Global Oral Codeine Tablet Sales by Region: 2025-2030
3.3 Global Oral Codeine Tablet Global Oral Codeine Tablet Revenue by Region: 2019-2030
3.3.1 Global Oral Codeine Tablet Revenue by Region: 2019-2024
3.3.2 Global Oral Codeine Tablet Revenue by Region: 2025-2030
3.4 North America Oral Codeine Tablet Market Facts & Figures by Country
3.4.1 North America Oral Codeine Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Codeine Tablet Sales by Country (2019-2030)
3.4.3 North America Oral Codeine Tablet Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Codeine Tablet Market Facts & Figures by Country
3.5.1 Europe Oral Codeine Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Codeine Tablet Sales by Country (2019-2030)
3.5.3 Europe Oral Codeine Tablet Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Codeine Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Codeine Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Codeine Tablet Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Codeine Tablet Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Codeine Tablet Market Facts & Figures by Country
3.7.1 Latin America Oral Codeine Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Codeine Tablet Sales by Country (2019-2030)
3.7.3 Latin America Oral Codeine Tablet Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Codeine Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Codeine Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Codeine Tablet Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Codeine Tablet Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Codeine Tablet Sales by Type (2019-2030)
4.1.1 Global Oral Codeine Tablet Sales by Type (2019-2024)
4.1.2 Global Oral Codeine Tablet Sales by Type (2025-2030)
4.1.3 Global Oral Codeine Tablet Sales Market Share by Type (2019-2030)
4.2 Global Oral Codeine Tablet Revenue by Type (2019-2030)
4.2.1 Global Oral Codeine Tablet Revenue by Type (2019-2024)
4.2.2 Global Oral Codeine Tablet Revenue by Type (2025-2030)
4.2.3 Global Oral Codeine Tablet Revenue Market Share by Type (2019-2030)
4.3 Global Oral Codeine Tablet Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Codeine Tablet Sales by Application (2019-2030)
5.1.1 Global Oral Codeine Tablet Sales by Application (2019-2024)
5.1.2 Global Oral Codeine Tablet Sales by Application (2025-2030)
5.1.3 Global Oral Codeine Tablet Sales Market Share by Application (2019-2030)
5.2 Global Oral Codeine Tablet Revenue by Application (2019-2030)
5.2.1 Global Oral Codeine Tablet Revenue by Application (2019-2024)
5.2.2 Global Oral Codeine Tablet Revenue by Application (2025-2030)
5.2.3 Global Oral Codeine Tablet Revenue Market Share by Application (2019-2030)
5.3 Global Oral Codeine Tablet Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Taiji Oral Codeine Tablet Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mallinckrodt Oral Codeine Tablet Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Oral Codeine Tablet Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Oral Codeine Tablet Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medreich Oral Codeine Tablet Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Aventis Oral Codeine Tablet Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Oral Codeine Tablet Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Oral Codeine Tablet Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pharmaceutical Associates Oral Codeine Tablet Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Oral Codeine Tablet Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Oral Codeine Tablet Description and Business Overview
6.11.3 Apotex Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Apotex Oral Codeine Tablet Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Oral Codeine Tablet Description and Business Overview
6.12.3 Mylan Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mylan Oral Codeine Tablet Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Oral Codeine Tablet Description and Business Overview
6.13.3 Aristo Pharma GmbH Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Aristo Pharma GmbH Oral Codeine Tablet Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Oral Codeine Tablet Description and Business Overview
6.14.3 Lannett Company Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lannett Company Oral Codeine Tablet Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Oral Codeine Tablet Description and Business Overview
6.15.3 Laboratoire Riva Oral Codeine Tablet Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Laboratoire Riva Oral Codeine Tablet Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Codeine Tablet Industry Chain Analysis
7.2 Oral Codeine Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Codeine Tablet Production Mode & Process
7.4 Oral Codeine Tablet Sales and Marketing
7.4.1 Oral Codeine Tablet Sales Channels
7.4.2 Oral Codeine Tablet Distributors
7.5 Oral Codeine Tablet Customers
8 Oral Codeine Tablet Market Dynamics
8.1 Oral Codeine Tablet Industry Trends
8.2 Oral Codeine Tablet Market Drivers
8.3 Oral Codeine Tablet Market Challenges
8.4 Oral Codeine Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Codeine Tablet Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Codeine Tablet Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Codeine Tablet Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Codeine Tablet Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Codeine Tablet Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Codeine Tablet Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Codeine Tablet Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Codeine Tablet Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Codeine Tablet, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Codeine Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Codeine Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Oral Codeine Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Codeine Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Codeine Tablet as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Codeine Tablet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Codeine Tablet Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Codeine Tablet Sales Market Share by Region (2019-2024)
Table 19. Global Oral Codeine Tablet Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Codeine Tablet Sales Market Share by Region (2025-2030)
Table 21. Global Oral Codeine Tablet Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Codeine Tablet Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Codeine Tablet Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Codeine Tablet Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Codeine Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Codeine Tablet Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Codeine Tablet Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Codeine Tablet Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Codeine Tablet Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Codeine Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Codeine Tablet Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Codeine Tablet Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Codeine Tablet Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Codeine Tablet Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Codeine Tablet Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Codeine Tablet Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Codeine Tablet Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Codeine Tablet Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Codeine Tablet Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Codeine Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Codeine Tablet Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Codeine Tablet Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Codeine Tablet Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Codeine Tablet Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Codeine Tablet Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Codeine Tablet Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Codeine Tablet Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Codeine Tablet Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Codeine Tablet Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Codeine Tablet Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Codeine Tablet Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Codeine Tablet Sales Market Share by Type (2019-2024)
Table 53. Global Oral Codeine Tablet Sales Market Share by Type (2025-2030)
Table 54. Global Oral Codeine Tablet Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Codeine Tablet Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Codeine Tablet Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Codeine Tablet Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Codeine Tablet Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Codeine Tablet Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Codeine Tablet Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Codeine Tablet Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Codeine Tablet Sales Market Share by Application (2019-2024)
Table 63. Global Oral Codeine Tablet Sales Market Share by Application (2025-2030)
Table 64. Global Oral Codeine Tablet Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Codeine Tablet Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Codeine Tablet Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Codeine Tablet Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Codeine Tablet Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Codeine Tablet Price (US$/Unit) by Application (2025-2030)
Table 70. Taiji Corporation Information
Table 71. Taiji Description and Business Overview
Table 72. Taiji Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Taiji Oral Codeine Tablet Product
Table 74. Taiji Recent Developments/Updates
Table 75. Mallinckrodt Corporation Information
Table 76. Mallinckrodt Description and Business Overview
Table 77. Mallinckrodt Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Mallinckrodt Oral Codeine Tablet Product
Table 79. Mallinckrodt Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Oral Codeine Tablet Product
Table 84. TEVA Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Oral Codeine Tablet Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Medreich Corporation Information
Table 91. Medreich Description and Business Overview
Table 92. Medreich Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Medreich Oral Codeine Tablet Product
Table 94. Medreich Recent Developments/Updates
Table 95. Sanofi Aventis Corporation Information
Table 96. Sanofi Aventis Description and Business Overview
Table 97. Sanofi Aventis Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Aventis Oral Codeine Tablet Product
Table 99. Sanofi Aventis Recent Developments/Updates
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cipla Oral Codeine Tablet Product
Table 104. Cipla Recent Developments/Updates
Table 105. Hikma Corporation Information
Table 106. Hikma Description and Business Overview
Table 107. Hikma Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hikma Oral Codeine Tablet Product
Table 109. Hikma Recent Developments/Updates
Table 110. Pharmaceutical Associates Corporation Information
Table 111. Pharmaceutical Associates Description and Business Overview
Table 112. Pharmaceutical Associates Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Pharmaceutical Associates Oral Codeine Tablet Product
Table 114. Pharmaceutical Associates Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Oral Codeine Tablet Product
Table 119. Novartis Recent Developments/Updates
Table 120. Apotex Corporation Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Apotex Oral Codeine Tablet Product
Table 124. Apotex Recent Developments/Updates
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Mylan Oral Codeine Tablet Product
Table 129. Mylan Recent Developments/Updates
Table 130. Aristo Pharma GmbH Corporation Information
Table 131. Aristo Pharma GmbH Description and Business Overview
Table 132. Aristo Pharma GmbH Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Aristo Pharma GmbH Oral Codeine Tablet Product
Table 134. Aristo Pharma GmbH Recent Developments/Updates
Table 135. Lannett Company Corporation Information
Table 136. Lannett Company Description and Business Overview
Table 137. Lannett Company Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lannett Company Oral Codeine Tablet Product
Table 139. Lannett Company Recent Developments/Updates
Table 140. Laboratoire Riva Corporation Information
Table 141. Laboratoire Riva Description and Business Overview
Table 142. Laboratoire Riva Oral Codeine Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Laboratoire Riva Oral Codeine Tablet Product
Table 144. Laboratoire Riva Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Codeine Tablet Distributors List
Table 148. Oral Codeine Tablet Customers List
Table 149. Oral Codeine Tablet Market Trends
Table 150. Oral Codeine Tablet Market Drivers
Table 151. Oral Codeine Tablet Market Challenges
Table 152. Oral Codeine Tablet Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Codeine Tablet
Figure 2. Global Oral Codeine Tablet Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Codeine Tablet Market Share by Type in 2023 & 2030
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Oral Codeine Tablet Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral Codeine Tablet Market Share by Application in 2023 & 2030
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Global Oral Codeine Tablet Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Codeine Tablet Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Codeine Tablet Sales (2019-2030) & (K Units)
Figure 14. Global Oral Codeine Tablet Average Price (US$/Unit) & (2019-2030)
Figure 15. Oral Codeine Tablet Report Years Considered
Figure 16. Oral Codeine Tablet Sales Share by Manufacturers in 2023
Figure 17. Global Oral Codeine Tablet Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Codeine Tablet Players: Market Share by Revenue in 2023
Figure 19. Oral Codeine Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Codeine Tablet Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Codeine Tablet Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Codeine Tablet Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Codeine Tablet Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Codeine Tablet Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Codeine Tablet Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Codeine Tablet Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Oral Codeine Tablet Sales Market Share by Country (2019-2030)
Figure 45. Latin America Oral Codeine Tablet Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Oral Codeine Tablet Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Oral Codeine Tablet Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Oral Codeine Tablet Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Codeine Tablet by Type (2019-2030)
Figure 55. Global Revenue Market Share of Oral Codeine Tablet by Type (2019-2030)
Figure 56. Global Oral Codeine Tablet Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Oral Codeine Tablet by Application (2019-2030)
Figure 58. Global Revenue Market Share of Oral Codeine Tablet by Application (2019-2030)
Figure 59. Global Oral Codeine Tablet Price (US$/Unit) by Application (2019-2030)
Figure 60. Oral Codeine Tablet Value Chain
Figure 61. Oral Codeine Tablet Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
